Collegium to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in three upcoming investor conferences in September 2025. The company will attend the 2025 Wells Fargo Healthcare Conference on September 4 in Boston, participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 8 at 2:35 p.m. ET in New York, and present at the H.C. Wainwright Global Investment Conference on September 9 at 10:30 a.m. ET in New York.

Live webcasts of the fireside chats will be accessible through Collegium's investor relations website, with replays available for 90 days after the presentations.

News Market Reaction

-1.13%

1 alert

-1.13% News Effect

On the day this news was published, COLL declined 1.13%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:

2025 Wells Fargo Healthcare Conference
Thursday, September 4, 2025
Boston, MA

Morgan Stanley 23rd Annual Global Healthcare Conference
Fireside Chat Date and Time: Monday, September 8, 2025 at 2:35 p.m. ET
New York, NY

A live webcast of the fireside chat will be available via the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

H.C. Wainwright 27th Annual Global Investment Conference
Fireside Chat Date and Time: Tuesday, September 9, 2025 at 10:30 a.m. ET
New York, NY

A live webcast of the fireside chat will be available via the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM^®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com

Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com

FAQ

When is Collegium Pharmaceutical (COLL) presenting at the Morgan Stanley Healthcare Conference 2025?

Collegium will participate in a fireside chat at the Morgan Stanley Healthcare Conference on Monday, September 8, 2025 at 2:35 p.m. ET in New York.

How can investors access Collegium's (COLL) conference presentations?

Investors can access the live webcasts through the Investors section of Collegium's website at https://ir.collegiumpharma.com. Replays will be available for 90 days following each presentation.

Which investor conferences will Collegium Pharmaceutical (COLL) attend in September 2025?

Collegium will attend three conferences: the Wells Fargo Healthcare Conference (Sept 4), Morgan Stanley Global Healthcare Conference (Sept 8), and H.C. Wainwright Global Investment Conference (Sept 9).

What time is Collegium's (COLL) presentation at the H.C. Wainwright Conference?

Collegium will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Tuesday, September 9, 2025 at 10:30 a.m. ET in New York.